Cargando…
Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315267/ http://dx.doi.org/10.1186/1479-5876-13-S1-O3 |
| _version_ | 1782355448253382656 |
|---|---|
| author | Daud, Adil Takamura, Kathryn Toshimi Diep, Tu Heller, Richard Pierce, Robert H |
| author_facet | Daud, Adil Takamura, Kathryn Toshimi Diep, Tu Heller, Richard Pierce, Robert H |
| author_sort | Daud, Adil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4315267 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43152672015-02-12 Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma Daud, Adil Takamura, Kathryn Toshimi Diep, Tu Heller, Richard Pierce, Robert H J Transl Med Oral Presentation BioMed Central 2015-01-15 /pmc/articles/PMC4315267/ http://dx.doi.org/10.1186/1479-5876-13-S1-O3 Text en Copyright © 2015 Daud et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Daud, Adil Takamura, Kathryn Toshimi Diep, Tu Heller, Richard Pierce, Robert H Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma |
| title | Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma |
| title_full | Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma |
| title_fullStr | Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma |
| title_full_unstemmed | Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma |
| title_short | Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma |
| title_sort | long-term overall survival from a phase i trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315267/ http://dx.doi.org/10.1186/1479-5876-13-S1-O3 |
| work_keys_str_mv | AT daudadil longtermoverallsurvivalfromaphaseitrialusingintratumoralplasmidinterleukin12withelectroporationinpatientswithmelanoma AT takamurakathryntoshimi longtermoverallsurvivalfromaphaseitrialusingintratumoralplasmidinterleukin12withelectroporationinpatientswithmelanoma AT dieptu longtermoverallsurvivalfromaphaseitrialusingintratumoralplasmidinterleukin12withelectroporationinpatientswithmelanoma AT hellerrichard longtermoverallsurvivalfromaphaseitrialusingintratumoralplasmidinterleukin12withelectroporationinpatientswithmelanoma AT pierceroberth longtermoverallsurvivalfromaphaseitrialusingintratumoralplasmidinterleukin12withelectroporationinpatientswithmelanoma |